These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15721757

  • 1. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?
    Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, Houle S, Meyer JH.
    Nucl Med Biol; 2005 Feb; 32(2):123-8. PubMed ID: 15721757
    [Abstract] [Full Text] [Related]

  • 2. Western blot analysis of human and rat serotonin transporter in platelets and brain using site-specific antibodies: evidence that transporter undergoes endoproteolytic cleavage.
    Dmitriev AD, Factor MI, Segal OL, Pavlova EV, Massino YS, Smirnova MB, Yakovleva DA, Dmitriev DA, Kizim EA, Kolyaskina GI, Brusov OS.
    Clin Chim Acta; 2005 Jun; 356(1-2):76-94. PubMed ID: 15936305
    [Abstract] [Full Text] [Related]

  • 3. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
    Szapacs ME, Mathews TA, Tessarollo L, Ernest Lyons W, Mamounas LA, Andrews AM.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):81-92. PubMed ID: 15589338
    [Abstract] [Full Text] [Related]

  • 4. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH.
    Synapse; 2003 Dec 01; 50(3):233-9. PubMed ID: 14515341
    [Abstract] [Full Text] [Related]

  • 5. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M.
    J Med Chem; 2005 Apr 07; 48(7):2559-70. PubMed ID: 15801845
    [Abstract] [Full Text] [Related]

  • 6. Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study.
    Kish SJ, Fitzmaurice PS, Chang LJ, Furukawa Y, Tong J.
    J Psychopharmacol; 2010 Feb 07; 24(2):281-4. PubMed ID: 18832433
    [Abstract] [Full Text] [Related]

  • 7. Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression.
    Rothman RB, Jayanthi S, Cadet JL, Wang X, Dersch CM, Baumann MH.
    Ann N Y Acad Sci; 2004 Oct 07; 1025():151-61. PubMed ID: 15542713
    [Abstract] [Full Text] [Related]

  • 8. Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain.
    Hipólide DC, Moreira KM, Barlow KB, Wilson AA, Nobrega JN, Tufik S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb 07; 29(2):297-303. PubMed ID: 15694238
    [Abstract] [Full Text] [Related]

  • 9. Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.
    Milak MS, Ogden RT, Vinocur DN, Van Heertum RL, Cooper TB, Mann JJ, Parsey RV.
    Biol Psychiatry; 2005 Jan 01; 57(1):102-6. PubMed ID: 15607307
    [Abstract] [Full Text] [Related]

  • 10. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter.
    Verney C, Lebrand C, Gaspar P.
    Anat Rec; 2002 Jun 01; 267(2):87-93. PubMed ID: 11997877
    [Abstract] [Full Text] [Related]

  • 11. Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT).
    Mochizuki H, Amano T, Seki T, Matsubayashi H, Mitsuhata C, Morita K, Kitayama S, Dohi T, Mishima HK, Sakai N.
    Neurochem Int; 2005 Jan 01; 46(2):93-105. PubMed ID: 15627510
    [Abstract] [Full Text] [Related]

  • 12. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.
    Nandi A, Dersch CM, Kulshrestha M, Ananthan S, Rothman RB.
    Synapse; 2004 Sep 01; 53(3):176-83. PubMed ID: 15236350
    [Abstract] [Full Text] [Related]

  • 13. 2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.
    Kung HF, Newman S, Choi SR, Oya S, Hou C, Zhuang ZP, Acton PD, Plössl K, Winkler J, Kung MP.
    J Med Chem; 2004 Oct 07; 47(21):5258-64. PubMed ID: 15456270
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).
    Li Q, Ma L, Innis RB, Seneca N, Ichise M, Huang H, Laruelle M, Murphy DL.
    J Pharmacol Exp Ther; 2004 Feb 07; 308(2):481-6. PubMed ID: 14610240
    [Abstract] [Full Text] [Related]

  • 15. 5-HT3A receptor subunits in the rat medial nucleus of the solitary tract: subcellular distribution and relation to the serotonin transporter.
    Huang J, Spier AD, Pickel VM.
    Brain Res; 2004 Dec 03; 1028(2):156-69. PubMed ID: 15527741
    [Abstract] [Full Text] [Related]

  • 16. Rat brain serotonin neurones that express neuronal nitric oxide synthase have increased sensitivity to the substituted amphetamine serotonin toxins 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
    De Silva DJ, French SJ, Cheung NY, Swinson AK, Bendotti C, Rattray M.
    Neuroscience; 2005 Dec 03; 134(4):1363-75. PubMed ID: 16054768
    [Abstract] [Full Text] [Related]

  • 17. ADAM is an effective tool for in vivo study of serotonergic function: validation in rat models.
    Chalon S, Bronquard C, Vercouillie J, Kodas E, Garreau L, Bodard S, Emond P, Besnard JC, Guilloteau D.
    Synapse; 2004 May 03; 52(2):136-42. PubMed ID: 15034919
    [Abstract] [Full Text] [Related]

  • 18. In vivo measurement of the serotonin transporter with (S)-([18F]fluoromethyl)-(+)-McN5652.
    Brust P, Hinz R, Kuwabara H, Hesse S, Zessin J, Pawelke B, Stephan H, Bergmann R, Steinbach J, Sabri O.
    Neuropsychopharmacology; 2003 Nov 03; 28(11):2010-9. PubMed ID: 12931143
    [Abstract] [Full Text] [Related]

  • 19. Characterization of an allosteric citalopram-binding site at the serotonin transporter.
    Chen F, Larsen MB, Neubauer HA, Sánchez C, Plenge P, Wiborg O.
    J Neurochem; 2005 Jan 03; 92(1):21-8. PubMed ID: 15606893
    [Abstract] [Full Text] [Related]

  • 20. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
    Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y.
    Brain; 2008 Jan 03; 131(Pt 1):120-31. PubMed ID: 17956909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.